Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00086411 · ClinicalTrials.gov registry record · Phase 2
Comparing Smoking Treatment Programs for Lighter Smokers - 1
A Phase 2 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 2
- Development phase
- 260
- Enrollment target
NCT00086411: Completed Phase 2 study, sponsored by University of Pennsylvania.
NCT00086411 is a Phase 2 study that has completed, run by University of Pennsylvania. The registered enrollment target is 260 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00086411, a Phase 2 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 260 participants
- Enrollment target
Study Summary
The purpose of this study was to compare two different types of Food and Drug Administration (FDA) approved smoking cessation medications (nicotine patch or bupropion) used in conjunction with two levels of counseling. It was hypothesized that the higher level of counseling would have the highest rates of treatment completion and highest rates of abstinence.
Primary Outcome
Completion of Treatment and Smoking Cessation by Two Different Types of Medications and Counseling Types at 12, 26, and 52 Weeks Post-treatment Initiation. The counseling types were Medication Management (MM) and Mayo counseling models. MM counseling was a 4 session lower intensity counseling model and Mayo counseling was a 10 session higher intensity model. A twofold definition of treatment completion included both medication and counseling session adherence. Treatment completion was defined a
Interventions
- DRUG nicotine transdermal system
- DRUG bupropion
- DRUG placebo patch
- BEHAVIORAL Medication Management
- BEHAVIORAL Mayo Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2003-09 |
| Est. Completion | 2009-06 |
| Phase | Phase 2 |
What the finished NCT00086411 record still lists
NCT00086411 is an interventional study that assigns participants to a tested intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% higher).
The record links to 0 conditions, and to 5 interventions - of which nicotine transdermal system is the first listed.
NCT00086411 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00086411 about?
NCT00086411 is a clinical study titled "Comparing Smoking Treatment Programs for Lighter Smokers - 1". The purpose of this study was to compare two different types of Food and Drug Administration (FDA) approved smoking cessation medications (nicotine patch or bupropion) used in conjunction with two levels of counseling. It was hypothesized that the higher level of counseling would have the highest ra...
What is the current status of trial NCT00086411?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 260 participants. The study started on 2003-09. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00086411?
The interventions under investigation include: nicotine transdermal system (DRUG), bupropion (DRUG), placebo patch (DRUG), Medication Management (BEHAVIORAL), Mayo Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT00086411?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00086411's enrollment target sits among peer trials
260 210th of 2000 higher than 1,789 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
- NCT03276793 · 260 participants · NA
Brain Connectivity in Depression
- NCT03407469 · 260 participants
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
- NCT03713125 · 260 participants · NA
Executive Function in Early Childhood
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia